Ani Pharmaceuticals (ANIP) FCF Margin (2010 - 2026)
Ani Pharmaceuticals' FCF Margin came in at 20.15% for Q2 2026, down 13.82 percentage points from 33.97% a year earlier and down 1.87 percentage points from the prior quarter.
Ani Pharmaceuticals (ANIP) FCF Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ani Pharmaceuticals reported FCF Margin of 17.68%, up 0.90 percentage points year-over-year; for FY2025, it came in at 19.40%, up 11.62 percentage points from FY2024.
- FCF Margin carries a five-year change of +15.02 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was 7.78% in FY2024 (-14.84 pp), 22.61% in FY2023 (+35.28 pp), -12.67% in FY2022 (-13.02 pp) and 0.35% in FY2021 (-4.03 pp).
- The five-year range for quarterly FCF Margin is -32.40% (Q1 2022) to 33.97% (Q2 2025).
- Year-over-year, FCF Margin increased in five of the last eight quarters, with an average year-over-year change of -0.51 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q1 2023 (a gain of 50.26 percentage points), and the weakest in Q1 2022 (a drop of 69.03 percentage points).
- Business Quant data shows ANIP's FCF Margin at 22.02% (Q1 2026), 11.79% (Q4 2025) and 16.66% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Ani Pharmaceuticals | 1.73 Bn | 512.62 Mn | 165.89 Mn | 20.15% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.15% |
| Mar 31, 2026 | 22.02% |
| Dec 31, 2025 | 11.79% |
| Sep 30, 2025 | 16.66% |
| Jun 30, 2025 | 33.97% |
| Mar 31, 2025 | 16.50% |
| Dec 31, 2024 | 7.07% |
| Sep 30, 2024 | 5.17% |
| Jun 30, 2024 | 9.39% |
| Mar 31, 2024 | 9.96% |
| Dec 31, 2023 | 32.25% |
| Sep 30, 2023 | 23.08% |
| Jun 30, 2023 | 15.55% |
| Mar 31, 2023 | 17.86% |
| Dec 31, 2022 | -8.00% |
| Sep 30, 2022 | 1.38% |
| Jun 30, 2022 | -17.34% |
| Mar 31, 2022 | -32.40% |
| Dec 31, 2021 | -20.58% |
| Sep 30, 2021 | -11.47% |
Ani Pharmaceuticals FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();